BACKGROUND: Research has begun to elucidate the optimal pharmacological treatments for pediatric-onset bipolar patients, but few studies have examined the role of psychosocial interventions as adjuncts to pharmacotherapy in maintenance treatment. This article describes an adjunctive family-focused psychoeducational treatment for bipolar adolescents (FFT-A). The adult version of FFT has been shown to be effective in forestalling relapses in two randomized clinical trials involving bipolar adults. METHODS: FFT-A is administered to adolescents who have had an exacerbation of manic, depressed, or mixed symptoms within the last 3 months. It is given in 21 outpatient sessions of psychoeducation, communication enhancement training, and problem solving skills training. We describe modifications to the adult FFT model to address the developmental issues and unique clinical presentations of pediatric-onset patients. RESULTS: An open treatment trial involving 20 bipolar adolescents (11 boys, 9 girls; mean age 14.8+/-1.6) found that the combination of FFT-A and mood stabilizing medications was associated with improvements in depression symptoms, mania symptoms, and behavior problems over 1 year. LIMITATIONS: These early results are based on a small-scale open trial. CONCLUSIONS: Results from an ongoing randomized controlled trial will clarify whether combining FFT-A with pharmacotherapy improves the 2-year course of adolescent bipolar disorder. If the results are positive, then a structured manual-based psychosocial approach will be available for clinicians who treat adolescent bipolar patients in the community.
BACKGROUND: Research has begun to elucidate the optimal pharmacological treatments for pediatric-onset bipolarpatients, but few studies have examined the role of psychosocial interventions as adjuncts to pharmacotherapy in maintenance treatment. This article describes an adjunctive family-focused psychoeducational treatment for bipolar adolescents (FFT-A). The adult version of FFT has been shown to be effective in forestalling relapses in two randomized clinical trials involving bipolar adults. METHODS: FFT-A is administered to adolescents who have had an exacerbation of manic, depressed, or mixed symptoms within the last 3 months. It is given in 21 outpatient sessions of psychoeducation, communication enhancement training, and problem solving skills training. We describe modifications to the adult FFT model to address the developmental issues and unique clinical presentations of pediatric-onset patients. RESULTS: An open treatment trial involving 20 bipolar adolescents (11 boys, 9 girls; mean age 14.8+/-1.6) found that the combination of FFT-A and mood stabilizing medications was associated with improvements in depression symptoms, mania symptoms, and behavior problems over 1 year. LIMITATIONS: These early results are based on a small-scale open trial. CONCLUSIONS: Results from an ongoing randomized controlled trial will clarify whether combining FFT-A with pharmacotherapy improves the 2-year course of adolescent bipolar disorder. If the results are positive, then a structured manual-based psychosocial approach will be available for clinicians who treat adolescent bipolarpatients in the community.
Authors: Mark S Bauer; Linda McBride; William O Williford; Henry Glick; Bruce Kinosian; Lori Altshuler; Thomas Beresford; Amy M Kilbourne; Martha Sajatovic Journal: Psychiatr Serv Date: 2006-07 Impact factor: 3.084
Authors: David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Stephen R Wisniewski; Jane N Kogan; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Laszlo Gyulai; Mako Araga; Jodi M Gonzalez; Edwin R Shirley; Michael E Thase; Gary S Sachs Journal: Arch Gen Psychiatry Date: 2007-04
Authors: Tina R Goldstein; David A Axelson; Boris Birmaher; David A Brent Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-07 Impact factor: 8.829
Authors: Rebecca S Siegel; Bettina Hoeppner; Shirley Yen; Robert L Stout; Lauren M Weinstock; Heather M Hower; Boris Birmaher; Tina R Goldstein; Benjamin I Goldstein; Jeffrey I Hunt; Michael Strober; David A Axelson; Mary Kay Gill; Martin B Keller Journal: J Nerv Ment Dis Date: 2015-03 Impact factor: 2.254
Authors: Matthew E Young; Thania Galvan; Brooke L Reidy; Matthew F Pescosolido; Kerri L Kim; Karen Seymour; Daniel P Dickstein Journal: J Affect Disord Date: 2013-05-22 Impact factor: 4.839
Authors: Rene L Olvera; Manoela Fonseca; Sheila C Caetano; John P Hatch; Kristina Hunter; Mark Nicoletti; Steven R Pliszka; C Robert Cloninger; Jair C Soares Journal: J Child Adolesc Psychopharmacol Date: 2009-02 Impact factor: 2.576
Authors: David J Miklowitz; Elizabeth L George; David A Axelson; Eunice Y Kim; Boris Birmaher; Christopher Schneck; Carol Beresford; W Edward Craighead; David A Brent Journal: J Affect Disord Date: 2004-10 Impact factor: 4.839